These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9163214)

  • 1. [A trial of using Geptral in patients with chronic liver diseases].
    Gorbakov VV; Kalinin AV; Ermolin SN
    Voen Med Zh; 1996 Dec; 317(12):29-31. PubMed ID: 9163214
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical trial of heptral in patients with chronic diffuse liver disease with intrahepatic cholestasis syndrome].
    Podymova SD; Nadinskaia MIu
    Klin Med (Mosk); 1998; 76(10):45-8. PubMed ID: 9865018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effectiveness of S-adenosylmethionine (SAM) in the treatment of chronic liver diseases].
    Silvi G; Rina D; Giannelli G
    Clin Ter; 1980 Feb; 92(3):241-50. PubMed ID: 7449310
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of heptral in chronic liver diseases].
    Vostrikov GP; Toporkov AS
    Eksp Klin Gastroenterol; 2002; (6):52-4, 113. PubMed ID: 12685015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic action of S-adenosylmethionine in some chronic hepatopathies].
    Labò G; Gasbarrini GB
    Minerva Med; 1975 May; 66(33):1563-70. PubMed ID: 1143692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The anti-steatosic effect of sulfo-adenosylmethionine (SAMe) in various forms of chronic hepatopathy. Multicentric research].
    Mazzanti R; Arcangeli A; Salvadori G; Smorlesi C; Di Perri T; Auteri A; Boggiano CA; Pippi L; Toti M; Boncompagni P; Angioli D; Caremani M; Magnolfi F; Camarri E; Motta R; Forconi A; Candidi Tommasi A; Lomi M; Soldi A
    Minerva Med; 1978 Oct; 69(48):3283-92. PubMed ID: 724140
    [No Abstract]   [Full Text] [Related]  

  • 7. [New trends in the therapy of chronic liver diseases. Significance of Sam-dependent transmethylations].
    Garassini G; Sarnari V
    Minerva Gastroenterol; 1974; 20(1):19-26. PubMed ID: 4827982
    [No Abstract]   [Full Text] [Related]  

  • 8. [Behaviour of ammonemia during treatment of chronic/hyperammonemic hepatopathy with S-adenosyl-L-methionine].
    De Caprio M; Carbone G; Cerotto GM; Corbosiero L; Vitale A
    Clin Ter; 1980 Mar; 92(6):587-602. PubMed ID: 7460488
    [No Abstract]   [Full Text] [Related]  

  • 9. S-adenosyl-L-methionine for treatment of depression, osteoarthritis, and liver disease.
    Hardy ML; Coulter I; Morton SC; Favreau J; Venuturupalli S; Chiappelli F; Rossi F; Orshansky G; Jungvig LK; Roth EA; Suttorp MJ; Shekelle P
    Evid Rep Technol Assess (Summ); 2003 Aug; (64):1-3. PubMed ID: 12899148
    [No Abstract]   [Full Text] [Related]  

  • 10. [Intrahepatic cholestasis in chronic liver diseases].
    Golovanova EV; Petrakov AV; Noskova KK
    Eksp Klin Gastroenterol; 2011; (2):58-67. PubMed ID: 21560642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Heptral in treating chronic liver diseases].
    Minushkin ON
    Eksp Klin Gastroenterol; 2002; (1):75-7. PubMed ID: 12271591
    [No Abstract]   [Full Text] [Related]  

  • 12. [Evaluation of the obstetrical risk in pregnant women with intrahepatic cholestasis treated with S-adenosyl-L-methionine].
    Lafuenti G; Plotti G; Nicolanti G; Gaglione R; Tibollo FG; Mancuso S
    Recenti Prog Med; 1988 Oct; 79(10):420-3. PubMed ID: 3247511
    [No Abstract]   [Full Text] [Related]  

  • 13. Oral S-adenosylmethionine in the symptomatic treatment of intrahepatic cholestasis. A double-blind, placebo-controlled study.
    Frezza M; Surrenti C; Manzillo G; Fiaccadori F; Bortolini M; Di Padova C
    Gastroenterology; 1990 Jul; 99(1):211-5. PubMed ID: 2188871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The pharmacological therapy of intrahepatic cholestasis].
    Coltorti M
    Ann Ital Med Int; 1993 Oct; 8 Suppl():41S-47S. PubMed ID: 8117520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [S-adenosylmethionine (SAM) in geriatric therapy].
    Jori E; Dallari A
    Minerva Med; 1973 Sep; 64(67):3485-91. PubMed ID: 4746873
    [No Abstract]   [Full Text] [Related]  

  • 16. [Relations between protidopoiesis and biological transmethylations: action of S-adenosylmethionine on protein crasis in chronic hepatopathies].
    Cantoni L; Maggi G; Mononi G; Preti G
    Minerva Med; 1975 May; 66(33):1581-9. PubMed ID: 1095963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A meta-analysis of therapeutic trials with ademetionine in the treatment of intrahepatic cholestasis].
    Frezza M
    Ann Ital Med Int; 1993 Oct; 8 Suppl():48S-51S. PubMed ID: 8117521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What is SAMe? S-Adenosylmethionine.
    Cowley G; Underwood A
    Newsweek; 1999 Jul; 134(1):46-50. PubMed ID: 10538206
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experience in heptral treatment of diffuse liver diseases].
    Gorbakov VV; Galik VP; Kirillov SM
    Ter Arkh; 1998; 70(10):82-6. PubMed ID: 9864813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of adenosyl-methionine in alcoholic liver disease and intrahepatic cholestasis.
    Testino G; Leone S; Fagoonee S; Pellicano R
    Minerva Gastroenterol Dietol; 2018 Sep; 64(3):187-189. PubMed ID: 29521488
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.